Divergence of growth hormone actions on hepatic drug metabolism in the presence and absence of the pituitary gland
Authors:
- Robert E. KramerRKRobert E. Kramer
- John W. GreinerJGJohn W. Greiner
- Howard D. ColbyHCHoward D. Colby
- 1 September 1975
- journal article
- Published by Elsevier in Life Sciences
- Vol. 17 (5) , 779-786
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Investigation of the effects of methyltestosterone, cortisone and spironolactone on the hepatic microsomal mixed function oxidase system in male and female ratsBiochemical Pharmacology, 1973
- Cytochrome P-450 and its Role in Drug MetabolismAnnual Review of Pharmacology, 1972
- Effect of Testosterone on Growth Hormone Secretion in Patients with Anorchia and Delayed PubertyThe Journal of Clinical Endocrinology & Metabolism, 1970
- III—GROWTH HORMONEThe Lancet, 1970
- Characteristics of nitro reduction of the carcinogenic agent, 4-nitroquinolone N-oxideBiochemical Pharmacology, 1970
- EFFECTS OF MORPHINE TREATMENT AND STARVATION ON THE SUBSTRATE INTERACTION WITH P-450 IN THE OXIDATION OF DRUGS BY LIVER MICROSOMESThe Japanese Journal of Pharmacology, 1970
- Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylationLife Sciences, 1969
- Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPHBiochemical and Biophysical Research Communications, 1968
- Growth Hormone Secretion Enhanced by AndrogenThe Journal of Clinical Endocrinology & Metabolism, 1968
- Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and anilineBiochemical Pharmacology, 1958